Project PEOLC02

Anticipatory Prescribing in Community End of Life Care: analysis of national policy documents

Analysis of national policy documents concerning anticipatory prescribing

Summary 

Anticipatory Prescribing of end-of-life medications in advance of need to be kept in a patient’s home or care home is widespread practice and endorsed by NICE as best practice in Palliative and end of life care. This study examined guidelines and policy documents published by Clinical Commissioning Groups, Trusts and hospices across the UK:

  1. Before the pandemic (Led by Richella Ryan)
  2. During the pandemic (Led by Meg Majumder)

Project activity 

  • Paper concerning analysis pre-pandemic now close to journal submission
  • Analysis of documents available during pandemic currently underway
  • Peer review journal publications
  • This study has led on to the current Region-wide audit of Anticipatory Prescribing being led by Stephen Barclay within the NHS England PEOLC Strategic Clinical Network

What we found and what this means 

  • Paper concerning analysis pre-pandemic now close to journal submission
  • Analysis of documents available during pandemic currently underway

Papers and resources

Read the paper, titled 'End of life care in UK care homes – controlled drugs: systematic review and narrative synthesis'

Who was involved?

Principal Investigator:

Stephen Barclay (sigb2@medschl.cam.ac.uk), University of Cambridge

Researchers and institutions:

Contact us

Stephen Barclay, sigb2@medschl.cam.ac.uk

PEOLC02